(133 days)
Not Found
No
The description focuses on passive marker tracking and software for surgical navigation based on pre-operative imaging or imageless models. There is no mention of AI or ML algorithms for image analysis, decision support, or other functions. The "Mentions AI, DNN, or ML" field is explicitly marked as "Not Found".
No
The device is a surgical navigation system intended to assist the surgeon in accurately locating anatomical structures, not to treat or cure a disease or condition.
No
The device is described as a surgical navigation system intended to assist surgeons in locating anatomical structures during orthopedic surgical procedures. It is used for guiding procedures rather than diagnosing a medical condition.
No
The device description explicitly states that the system includes "general instrumentation" and "passive markers" which are physical hardware components tracked by a camera. While it uses software, it is not solely software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens taken from the human body (like blood, urine, or tissue) to provide information about a person's health.
- Device Function: The EBI® Acumen™ Surgical Navigation System is used during surgical procedures to assist the surgeon in locating anatomical structures. It uses imaging data (CT, MRI, fluoroscopy, or imageless models) and tracks instruments relative to the patient's anatomy.
- Lack of Specimen Analysis: The description does not mention the analysis of any biological specimens taken from the patient. Its function is entirely focused on surgical guidance and navigation based on imaging and instrument tracking.
Therefore, the device falls under the category of a surgical navigation system, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The EBI® Acumen™ Surgical Navigation System is intended to assist the surgeon in accurately locating anatomical structures during open or percutaneous orthopedic surgical procedures. The EBI® Acumen™ Surgical Navigation System is indicated for use in spine and trauma procedures, in which the use of stereotaxic surgery may be appropriate, and where reference to rigid anatomical bony structures can be identified relative to a CT or MRI based model, fluoroscopy or an imageless model of the anatomy.
Product codes
HAW
Device Description
The EBI® Acumen Surgical Navigation System includes general instrumentation that is utilized with application specific software developed and supplied by Z-Kat, Inc., Hollywood, FL.
Passive markers(spheres) are attached onto the Acumen instrumentation. An infrared light source generated by the camera refects off the passive markers to allow their position and orientation to be identified. The Acumen instruments are used as: 1) an independent instrument, 2) connected to instruments, which are attached to the patient, or 3) connected to the associated implant preparation and insertion instrumentation.
All Acumen instruments will have a minimum of three (3) passive markers to be tracked by the camera. They will be rigidly connected to the instrumentation utilized in the surgical procedure and will have a defined geometry of the passive marker position for a unique identification by the camera and software system.
The instruments can be utilized in spine and trauma procedures and are designed as single use components.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT or MRI based model, fluoroscopy or an imageless model of the anatomy.
Anatomical Site
rigid anatomical bony structures
Indicated Patient Age Range
Not Found
Intended User / Care Setting
surgeon, orthopedic surgical procedures
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
OCT 1 5 2003
K03/732
510(k) Summary of Safety & Effectiveness
This 510(k) Summary of Safety and Effectiveness for the EBI® Acumen Surgical Navigation System is provided as required per Section 513(1)(3) of the Food, Drug and Cosmetic Act.
-
EBI, L.P. Contact Person: Jon Caparotta 1. Submitter: 100 Interpace Parkway Tel: (973) 299-9300,x3964 Parsippany. NJ 07054
Date prepared: 8/18/03 -
- Proprietary Name: EBI® Acumen Surgical Navigation System Common Name: Instrumentation, Stereotaxic Classification Name: Stereotaxic Instrument (21CFR 882.4560)
-
- Predicate or legally marketed* devices that are substantially equivalent:
Voyager Linux | (K023975) |
---|---|
FluroLab Plus | (K013025) |
Z-Box | (K030764) |
-
- Description of the device: The EBI® Acumen Surgical Navigation System includes general instrumentation that is utilized with application specific software developed and supplied by Z-Kat, Inc., Hollywood, FL.
Passive markers(spheres) are attached onto the Acumen instrumentation. An infrared light source generated by the camera refects off the passive markers to allow their position and orientation to be identified. The Acumen instruments are used as: 1) an independent instrument, 2) connected to instruments, which are attached to the patient, or 3) connected to the associated implant preparation and insertion instrumentation.
- Description of the device: The EBI® Acumen Surgical Navigation System includes general instrumentation that is utilized with application specific software developed and supplied by Z-Kat, Inc., Hollywood, FL.
All Acumen instruments will have a minimum of three (3) passive markers to be tracked by the camera. They will be rigidly connected to the instrumentation utilized in the surgical procedure and will have a defined geometry of the passive marker position for a unique identification by the camera and software system.
The instruments can be utilized in spine and trauma procedures and are designed as single use components.
-
- Intended Use: The EBI Acumen™ Surgical Navigation System is intended to assist the surgeon in accurately locating anatomical structures during open or percutaneous orthopedic surgical procedures. The EBI Acumen" System is indicated for use in spine and trauma procedures, in which the use of stereotactic surgery may be appropriate, and where reference to rigid anatomical bony structures can be identified relative to a CT or MRI based model, fluoroscopy or an imageless model of the anatomy.
-
- Materials: The instruments are manufactured from: ABS Thermoplastic Polymer (Acrylonitrile Butadiene Styrene), Stainless Steel, Aluminum Alloy, Dupont Hytrel #5526 Natural, Loctite, Rigid PVC Clear Film, Reflective Material - Silver Transfer Film, 410 or 420 Stainless Steel.
1
-
- Comparison of the technological characteristics of the device to predicate devices: There are no significant differences between the EBI® Acumen Surgical Navigation System and other Systems currently on the market. It is substantially equivalent* to the predicate device(s) in technological characteristics and intended use. Software verification and validation was performed to establish substantial equivalence to the predicate systems.
*Any statement made in conjunction with this submission regarding a determination of substantial equivalence to any other product is intended only to relate to whether the product can be lawfully marketed without pre-market approval or reclassification and is not intended to be interpreted as an admission or any other type of evidence in patent infringement litigation. [Establishment Registration and Premarket Notification Procedures, Final Regulation, Preamble, August 23, 1977, FR 42520 (Docket No. 76N-0355.)]
- Comparison of the technological characteristics of the device to predicate devices: There are no significant differences between the EBI® Acumen Surgical Navigation System and other Systems currently on the market. It is substantially equivalent* to the predicate device(s) in technological characteristics and intended use. Software verification and validation was performed to establish substantial equivalence to the predicate systems.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health and Human Services. The logo features a stylized image of a human figure with three lines representing the body and head. The figure is enclosed in a circle with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" around the perimeter of the circle. The text is in all caps and is evenly spaced around the circle.
Public Health Service
OCT 1 5 2003
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Mr. Jon Caparotta, RAC Manager, Regulatory Affairs EBI. L.P. 100 Interpace Parkway Parsippany, New Jersey 07054
Re: K031732
Trade/Device Name: EBI Acumen™ Surgical Navigation System Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: II Product Code: HAW Dated: August 20, 2003 Received: August 21, 2003
Dear Mr. Caparotta:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice reguirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Mr. Jon Caparotta, RAC
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
Mark A. Melkus
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Statement of Indications for Use
Page_1_of_
Ko31732 510(k) Number (if known):
Device Name: EBI® Acumen™ Surgical Navigation System
Indications For Use:
The EBI® Acumen™ Surgical Navigation System is intended to assist the surgeon in accurately locating anatomical structures during open or percutaneous orthopedic surgical procedures. The EBI® Acumen™ Surgical Navigation System is indicated for use in spine and trauma procedures, in which the use of stereotaxic surgery may be appropriate, and where reference to rigid anatomical bony structures can be identified relative to a CT or MRI based model, fluoroscopy or an imageless model of the anatomy.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use U (Per 21 CFR 801.109)
OR
Over-The-Counter Use (Optional Format 1-2-96)
for Mark N Mellem
neral, Restorative d Neurological Devices
510(k) Number K031732